Practice Bulletin No. 157: Cervical Cancer Screening and Prevention

doi:10.1097/aog.0000000000001263

Cited by 118Cervical Cancer and HPV ResearchWomen's cancer prevention and managementEndometrial and Cervical Cancer Treatments

Practice Bulletin No. 157: Cervical Cancer Screening and Prevention

·2016·Obstetrics & Gynecology

DOI 10.1097/aog.0000000000001263

Open this paper in CoChat — free account

Abstract

The incidence of cervical cancer in the United States has decreased more than 50% in the past 30 years because of widespread screening. In 1975, the rate was 14.8 per 100,000 women. By 2011, it decreased to 6.7 per 100,000 women. Mortality from the disease has undergone a similar decrease from 5.55 per 100,000 women in 1975 to 2.3 per 100,000 women in 2011 (). The American Cancer Society (ACS) estimated that there would be 12,900 new cases of cervical cancer in the United States in 2015, with 4,100 deaths from the disease (). Cervical cancer is much more common worldwide, particularly in countries without screening programs, with an estimated 527,624 new cases of the disease and 265,672 resultant deaths each year (). When cervical cancer screening programs have been introduced into communities, marked reductions in cervical cancer incidence have followed ().New technologies for cervical cancer screening continue to evolve, as do recommendations for managing the results. In addition, there are different risk-benefit considerations for women at different ages, as reflected in age-specific screening recommendations. In 2011, the ACS, the American Society for Colposcopy and Cervical Pathology (ASCCP), and the American Society for Clinical Pathology (ASCP) updated their joint guidelines for cervical cancer screening (), as did the U.S. Preventive Services Task Force (USPSTF) (). Subsequently, in 2015, ASCCP and the Society of Gynecologic Oncology (SGO) issued interim guidance for the use of a human papillomavirus (HPV) test for primary screening for cervical cancer that was approved in 2014 by the U.S. Food and Drug Administration (FDA) (). The purpose of this document is to provide a review of the best available evidence regarding the prevention and early detection of cervical cancer.

Integrity signals

Registry

Crossref · 10.1097/aog.0000000000001263

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

USPSTF and ACOG recommend that cervical cancer screening begin at age 21 years.
“Guidelines from USPSTF and ACOG recommend that cervical cancer screening begin at age 21 years (174,175).”
From Sexually Transmitted Infections Treatment Guidelines, 2021 (2021) · cites this paper as [175]

Sorted by citations

Sexually Transmitted Infections Treatment Guidelines, 2021
Workowski, K. A., Bachmann, L. H., Chan, P. A., Johnston, C. M., Muzny, C. A., Park, I., Reno, H., Zenilman, J. M., & Bolan, G. A. (2021) · MMWR. Recommendations and Reports · doi:10.15585/mmwr.rr7004a1 · Cited by 2,759 · see citing works
ACG clinical guideline: Preventive care in inflammatory bowel disease
Farraye, F. A., Melmed, G. Y., Lichtenstein, G. R., & Kane, S. V. (2017) · American Journal of Gastroenterology · doi:10.1038/ajg.2016.537 · Cited by 473 · see citing works
The precision prevention and therapy of HPV ‐related cervical cancer: new concepts and clinical implications
Hu, Z., & Ma, D. (2018) · Cancer Medicine · doi:10.1002/cam4.1501 · Cited by 345 · see citing works
Domestic HPV vaccine price and economic returns for cervical cancer prevention in China: a cost-effectiveness analysis
Zou, Z., Fairley, C. K., Ong, J. J., et al. (2020) · The Lancet Global Health · doi:10.1016/s2214-109x(20)30277-1 · Cited by 177 · see citing works
Human papillomavirus infection in solid organ transplant recipients: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice
Chin-Hong, P. V., Reid, G., & Practice, T. A. I. D. C. O. (2019) · Clinical Transplantation · doi:10.1111/ctr.13590 · Cited by 127 · see citing works
Test performance and acceptability of self- versus provider-collected swabs for high-risk HPV DNA testing in female-to-male trans masculine patients.
Reisner, S. L., Deutsch, M. B., Peitzmeier, S. M., White Hughto, J. M., Cavanaugh, T. P., Pardee, D. J., McLean, S. A., Panther, L. A., Gelman, M., Mimiaga, M. J., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0190172 · Cited by 126 · see citing works
Significant variations in the cervical cancer screening rate in China by individual‐level and geographical measures of socioeconomic status: a multilevel model analysis of a nationally representative survey dataset
Bao, H., Zhang, L., Wang, L., Zhang, M., Zhao, Z., Fang, L., Cong, S., Zhou, M., & Wang, L. (2018) · Cancer Medicine · doi:10.1002/cam4.1321 · Cited by 100 · see citing works
Aging with HIV in the ART era
Kaplan‐Lewis, E., Aberg, J. A., & Lee, M.-K. (2017) · Seminars in Diagnostic Pathology · doi:10.1053/j.semdp.2017.04.002 · Cited by 75 · see citing works
Cervical Cancer Screening and Incidence by Age: Unmet Needs Near and After the Stopping Age for Screening
White, M. C., Shoemaker, M. L., & Benard, V. B. (2017) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2017.02.024 · Cited by 64 · see citing works
Utility of gene methylation analysis, cytological examination, and HPV-16/18 genotyping in triage of high-risk human papilloma virus-positive women
Tian, Y., Wu, N., Liou, Y., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.19459 · Cited by 55 · see citing works
Leptin Regulation of Cancer Stem Cells in Breast and Gynecologic Cancer
Crean-Tate, K., & Reizes, O. (2018) · Endocrinology · doi:10.1210/en.2018-00379 · Cited by 54 · see citing works
Cervical Cancer Screening
Gavinski, K., & DiNardo, D. J. (2022) · Medical Clinics of North America · doi:10.1016/j.mcna.2022.10.006 · Cited by 49 · see citing works
Factors Associated with Uptake of Visual Inspection with Acetic Acid (VIA) for Cervical Cancer Screening in Western Kenya
Orang’o, O., Wachira, J., Asirwa, F. C., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0157217 · Cited by 49 · see citing works
Human Papillomavirus in Kidney Transplant Recipients
Chin-Hong, P. V. (2016) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2016.05.016 · Cited by 46 · see citing works
HPV genotypic spectrum in Jilin province, China, where non-vaccine-covered HPV53 and 51 are prevalent, exhibits a bimodal age-specific pattern
Hao, S., Wang, C., Liu, S., He, J., & Jiang, Y. (2020) · PLoS ONE · doi:10.1371/journal.pone.0230640 · Cited by 45 · see citing works
Prevalence of and Factors Associated With Receiving a Pelvic Examination or Pap Testing Under the Age of 21 Years
Mason, R. E., Sappenfield, O. R., Turyk, M. E., et al. (2020) · Journal of Adolescent Health · doi:10.1016/j.jadohealth.2020.03.002 · Cited by 44 · see citing works
AGA Clinical Practice Update on Noncolorectal Cancer Screening and Vaccinations in Patients With Inflammatory Bowel Disease: Expert Review
Caldera, F., Kane, S. V., Long, M. D., et al. (2025) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2024.12.011 · Cited by 42 · see citing works
Cervical Cancer Incidence Among Elderly Women in Massachusetts Compared With Younger Women
Feldman, S., Cook, E. E., Davis, M., et al. (2018) · Journal of Lower Genital Tract Disease · doi:10.1097/lgt.0000000000000435 · Cited by 39 · see citing works
Cervical Cancer Screening
Sawaya, G. F., & Huchko, M. J. (2017) · Medical Clinics of North America · doi:10.1016/j.mcna.2017.03.006 · Cited by 38 · see citing works
CD200Fc reduces LPS-induced IL-1β activation in human cervical cancer cells by modulating TLR4-NF-κB and NLRP3 inflammasome pathway
He, A., Shao, J., Zhang, Y. L., Lu, H., Wu, Z., & Xu, Y. (2017) · Oncotarget · doi:10.18632/oncotarget.16596 · Cited by 37 · see citing works
Cervical cancer
Wuerthner, B. A., & Avila-Wallace, M. (2016) · The Nurse Practitioner · doi:10.1097/01.npr.0000490390.43604.5f · Cited by 36 · see citing works
LINE-1 hypermethylation in white blood cell DNA is associated with high-grade cervical intraepithelial neoplasia
Barchitta, M., Quattrocchi, A., Maugeri, A., Cantó, C. O., Rosa, N. L., Cantarella, M. A., Spampinato, G., Scalisi, A., & Agodi, A. (2017) · BMC Cancer · doi:10.1186/s12885-017-3582-0 · Cited by 32 · see citing works
Rates of Cervical Cancer Screening Among Women With Severe Mental Illness in the Public Health System
James, M. C., Thomas, M., Frolov, L., et al. (2017) · Psychiatric Services · doi:10.1176/appi.ps.201600293 · Cited by 32 · see citing works
Risk of human papillomavirus infection in women with rheumatic disease: cervical cancer screening and prevention
Kim, S. C., Feldman, S., & Moscicki, A. (2017) · Lara D. Veeken · doi:10.1093/rheumatology/kex523 · Cited by 31 · see citing works
Prevention of human papillomavirus (HPV)-related tumors in people living with human immunodeficiency virus (HIV)
Poljak, M., Šterbenc, A., & Lunar, M. M. (2017) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2017.1392854 · Cited by 30 · see citing works
PERFORMANCE OF SMARTPHONE-BASED DIGITAL IMAGES FOR CERVICAL CANCER SCREENING IN A LOW-RESOURCE CONTEXT
Tran, P. L., Benski, A. C., Viviano, M., et al. (2018) · International Journal of Technology Assessment in Health Care · doi:10.1017/s0266462318000260 · Cited by 29 · see citing works
Observed Colposcopy Practice in US Community-Based Clinics: The Retrospective Control Arm of the IMPROVE-COLPO Study
Huh, W. K., Papagiannakis, E., & Gold, M. A. (2019) · Journal of Lower Genital Tract Disease · doi:10.1097/lgt.0000000000000454 · Cited by 24 · see citing works
Cervical Cancer Screening Among Immigrant and Refugee Women: Scoping-Review and Directions for Future Research
Abdi, H. I., Hoover, E., Fagan, S. E., et al. (2020) · Journal of Immigrant and Minority Health · doi:10.1007/s10903-020-01014-5 · Cited by 24 · see citing works
Cervical Cancer Screening with HPV Testing: Updates on the Recommendation
Carvalho, C. F., Teixeira, J. C., Bragança, J. F., Derchain, S., Zeferino, L. C., & Vale, D. B. (2022) · Revista Brasileira Ginecologia e Obstetrícia · doi:10.1055/s-0041-1739314 · Cited by 36 · see citing works
Triage of Women Testing Positive With the careHPV Test on Self-Collected Vaginal Samples for Cervical Cancer Screening in a Low-Resource Setting
Poli, U. R., Gowrishankar, S., Swain, M., & Jerónimo, J. (2017) · Journal of Global Oncology · doi:10.1200/jgo.2016.008078 · Cited by 24 · see citing works
Correlates of Cervical Cancer Screening Adherence Among Women in the U.S.: Findings from HINTS 2013–2014
Luque, J. S., Tarasenko, Y. N., & Chen, C. (2018) · The Journal of Primary Prevention · doi:10.1007/s10935-018-0513-z · Cited by 24 · see citing works
The performance of human papillomavirus DNA detection with type 16/18 genotyping by hybrid capture in primary test of cervical cancer screening: a cross-sectional study in 10,669 Chinese women
Zhao, X., Wu, Q., Wang, X., Fu, Y., Zhang, X., Tian, X., Cheng, B., Lü, B., Yu, X., Lan, S., et al. (2018) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2018.02.027 · Cited by 23 · see citing works
Comparative analysis of robotic vs laparoscopic radical hysterectomy for cervical cancer
Chen, L., Liu, L., Wen, N., et al. (2019) · World Journal of Clinical Cases · doi:10.12998/wjcc.v7.i20.3185 · Cited by 22 · see citing works
Exploring the barriers to Pap smear test in Iranian women: a qualitative study
Marashi, T., Irandoost, S. F., Lebni, J. Y., & Soofizad, G. (2021) · BMC Women s Health · doi:10.1186/s12905-021-01428-9 · Cited by 24 · see citing works
Human Papillomavirus and Its Testing Assays, Cervical Cancer Screening, and Vaccination
Zhu, Y., Wang, Y., Hirschhorn, J. W., Welsh, K. J., Zhao, Z., Davis, M., & Feldman, S. (2017) · Advances in clinical chemistry · doi:10.1016/bs.acc.2017.01.004 · Cited by 21 · see citing works
Risk Factors for Human Papillomavirus Infection and Abnormal Cervical Cytology Among Perinatally Human Immunodeficiency Virus-Infected and Uninfected Asian Youth
Sohn, A. H., Kerr, S. J., Hansudewechakul, R., et al. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/ciy144 · Cited by 22 · see citing works
Human Papillomavirus Genotyping Testing Practice in 2014: Results of a College of American Pathologists National Survey
Zhao, C., Crothers, B. A., Ghofrani, M., et al. (2016) · Archives of Pathology & Laboratory Medicine · doi:10.5858/arpa.2016-0061-cp · Cited by 21 · see citing works
Evaluation of p16/Ki-67 dual staining in the detection of cervical precancer and cancer in China
Zhang, S., Jia, M., Zhao, D., et al. (2019) · Cancer Epidemiology · doi:10.1016/j.canep.2018.12.013 · Cited by 21 · see citing works
Application of Da Vinci robotic surgery system in cervical cancer: A single institution experience of 557 cases
Li, J., Gong, X., Li, P., et al. (2021) · Asian Journal of Surgery · doi:10.1016/j.asjsur.2021.07.052 · Cited by 19 · see citing works
Primary HPV testing: U.S. women's awareness and acceptance of an emerging screening modality
Saraiya, M., Kwan, A. K., & Cooper, C. P. (2017) · Preventive Medicine · doi:10.1016/j.ypmed.2017.12.007 · Cited by 19 · see citing works
Provider‐Identified Barriers to Cervical Cancer Screening and Perceptions Toward Self‐Collection of Human Papillomavirus in Southwest Virginia
Garcia, C. A., Lothamer, H., & Mitchell, E. M. (2016) · Public Health Nursing · doi:10.1111/phn.12285 · Cited by 18 · see citing works
Current and Emerging Molecular Tests for Human Papillomavirus–Related Neoplasia in the Genomic Era
Leal, S. M., & Gulley, M. L. (2017) · Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2017.01.006 · Cited by 19 · see citing works
Detoxification therapy of traditional Chinese medicine for genital tract high-risk human papillomavirus infection: A systematic review and meta-analysis
Luo, M., Yu, J., Zhu, S., et al. (2019) · PLoS ONE · doi:10.1371/journal.pone.0213062 · Cited by 18 · see citing works
Human papillomavirus infection
Hutter, J. N., & Decker, C. F. (2016) · Disease-a-Month · doi:10.1016/j.disamonth.2016.03.014 · Cited by 18 · see citing works
Primary HPV testing recommendations of US providers, 2015
Cooper, C. P., & Saraiya, M. (2017) · Preventive Medicine · doi:10.1016/j.ypmed.2017.08.006 · Cited by 17 · see citing works
Cervical Cancer Screening Intervals Preferred by U.S. Women
Cooper, C. P., & Saraiya, M. (2018) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2018.04.028 · Cited by 17 · see citing works
Triage by PAX1 and ZNF582 Methylation in Women With Cervical Intraepithelial Neoplasia Grade 3: A Multicenter Case–Control Study
Fu, K., Lei, M., Wu, L., et al. (2022) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofac013 · Cited by 17 · see citing works
Clinical evaluation of a real-time optoelectronic device in cervical cancer screening
Wei, Y., Wang, W., Cheng, M., Hong, Z., Gu, L., Niu, J., Di, W. J., & Qiu, L. (2021) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2021.09.027 · Cited by 17 · see citing works
Optimal cutoff level of serum squamous cell carcinoma antigen to detect recurrent cervical squamous cell carcinoma during post-treatment surveillance
Oh, J., & Bae, J. Y. (2018) · Obstetrics & Gynecology Science · doi:10.5468/ogs.2018.61.3.337 · Cited by 16 · see citing works
Importance of Colposcopy Impression in the Early Diagnosis of Posthysterectomy Vaginal Cancer
Cong, Q., Fu, Z., Zhang, D., et al. (2018) · Journal of Lower Genital Tract Disease · doi:10.1097/lgt.0000000000000446 · Cited by 16 · see citing works
Epidemiology and Risk Factors for Cervical Cancer
Agustiansyah, P., Sanif, R., Nurmaini, S., et al. (2021) · Bioscientia Medicina Journal of Biomedicine and Translational Research · doi:10.32539/bsm.v5i7.326 · Cited by 15 · see citing works
The Mitigation of Racial Disparities in Cervical Cancer Screening Among U.S. Active Duty Service Women
Pope, J., Banaag, A. L., Madsen, C., Hanson, T. M., Khan, M., & Koehlmoos, T. P. (2020) · Military Medicine · doi:10.1093/milmed/usaa427 · Cited by 16 · see citing works
Health Maintenance Consensus for Adults With Inflammatory Bowel Disease
Syal, G., Serrano, M., Jain, A., Cohen, B. L., Rieder, F., Stone, C. D., Abraham, B. P., Hudesman, D. P., Malter, L. B., McCabe, R. P., et al. (2021) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izab155 · Cited by 14 · see citing works
Health Maintenance for Adult Patients with Inflammatory Bowel Disease
Hashash, J. G., Picco, M. F., & Farraye, F. A. (2021) · Current Treatment Options in Gastroenterology · doi:10.1007/s11938-021-00364-9 · Cited by 12 · see citing works
Cervical Cancer Screening for Women Living With HIV
Chapman, C. L., & Harris, A. L. (2016) · Nursing for Women s Health · doi:10.1016/j.nwh.2016.07.002 · Cited by 11 · see citing works
Trends in single women with malignancy of the uterine cervix in United States
Machida, H., Blake, E. A., Eckhardt, S. E., et al. (2017) · Journal of Gynecologic Oncology · doi:10.3802/jgo.2018.29.e24 · Cited by 11 · see citing works
Recent Penile Sexual Contact Is Associated With an Increased Odds of High-Risk Cervical Human Papillomavirus Infection in Transgender Men
Deutsch, M. B., Reisner, S. L., Peitzmeier, S. M., Potter, J. E., Pardee, D. J., & Hughto, J. M. W. (2019) · Sexually Transmitted Diseases · doi:10.1097/olq.0000000000001072 · Cited by 11 · see citing works
A comparison of high‐risk human papillomavirus DNA detection between urine and cervical sample testing in women with abnormal Pap smears
Punyashthira, A., Horthongkham, N., Jaishuen, A., Jareemit, N., & Achariyapota, V. (2021) · Journal of obstetrics and gynaecology research · doi:10.1111/jog.15095 · Cited by 9 · see citing works
Clinical Characteristics and Outcomes Among Older Women with HIV
Frazier, E. L., Sutton, M. Y., Tie, Y., Collison, M. W., & Do, A. (2017) · Journal of Women s Health · doi:10.1089/jwh.2017.6380 · Cited by 9 · see citing works
Shotgun Lipidomics for Differential Diagnosis of HPV-Associated Cervix Transformation
Starodubtseva, N. L., Chagovets, V., Nekrasova, M. E., Мирзоевна, Н. Н., Tokareva, A., Bourmenskaya, O., Attoeva, D. I., Kukaev, E., Trofimov, D. Y., Евгеньевич, Ф. В., et al. (2022) · Metabolites · doi:10.3390/metabo12060503 · Cited by 10 · see citing works
High unmet needs for cervical cancer screening among women living with HIV in six African countries: A population-based study
Alpar, A. D., Ndiaye, C., Guillaume, D., et al. (2025) · International Journal of STD & AIDS · doi:10.1177/09564624251315787 · Cited by 7 · see citing works
Comparative Efficacy and Safety of Chinese Patent Medicines for Cervical High-risk Human Papillomavirus Infection: A Bayesian Network Meta-analysis
Bin, C., Zhong, H., Mo, J., Wang, Z., Li, M., & Wei, S. (2023) · Journal of Cancer · doi:10.7150/jca.86043 · Cited by 7 · see citing works
P16INK4a/ki67 Immunocytochemistry in Improving the Predictive Value for High Grade Cervical Intraepithelial (≥CIN2) Neoplasia in Pap Smear
Kumar, G. V., Prabhu, A. J., Sebastian, A., Raghavendran, Abraham, P., & Peedicayil, A. (2021) · Journal of Cytology · doi:10.4103/joc.joc_245_20 · Cited by 7 · see citing works
Comparison of Visual Inspection Methods Using Either Acetic Acid Solution or Lugol’s Iodine Solution with Colposcopy in Screening of Cervical Cancer: A Cross Sectional Study
Tehranian, A., Ghahghaei‐Nezamabadi, A., Langeroudi, M. M., et al. (2022) · Journal of Obstetrics Gynecology and Cancer Research · doi:10.30699/jogcr.8.1.53 · Cited by 7 · see citing works
Cervical cancer screening in women over 65. CON: Reasons for uncertainty
Sawaya, G. F. (2016) · Gynecologic Oncology · doi:10.1016/j.ygyno.2016.08.229 · Cited by 7 · see citing works
Prevalence threshold of screening tests in obstetrics and gynecology
Elfassy, L., Lasry, A., Gil, Y., & Balayla, J. (2021) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2021.02.015 · Cited by 7 · see citing works
The Development of Human Papillomavirus (HPV) Vaccines and Current Barriers to Implementation
Butterfield, R., & Dhanani, S. (2021) · Immunological Investigations · doi:10.1080/08820139.2021.1897612 · Cited by 7 · see citing works
Hysterectomy in the Urologist’s Practice
Weissbart, S. J., & Smith, A. L. (2017) · Current Urology Reports · doi:10.1007/s11934-017-0654-2 · Cited by 7 · see citing works
Comparison of CerviHPV and Hybrid Capture 2 HPV tests for detection of high‐risk HPV infection in cervical swab specimens
Zhao, G., Tian, Y., Du, Y., et al. (2018) · Diagnostic Cytopathology · doi:10.1002/dc.24134 · Cited by 7 · see citing works
Epidemiology and Risk Factors for Cervical Cancer
Agustiansyah, P., Sanif, R., Nurmaini, S., et al. (2021) · Bioscientia Medicina Journal of Biomedicine and Translational Research · doi:10.32539/bsm.v5i3.326 · Cited by 6 · see citing works
Elevated risk of cervical cancer in elderly women with incident ulcerative colitis in South Korea
Kim, J. H., Jo, H., Ha, M. C., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-33476-6 · Cited by 6 · see citing works
Discovery of Candidate Gene Expression Signatures in Peripheral Blood for the Screening of Cervical Cancer
Ma, Q., Shao, Y., Chen, W., et al. (2020) · Biomarkers in Medicine · doi:10.2217/bmm-2019-0247 · Cited by 6 · see citing works
Recognition and Therapeutic Options for Malignancy of the Cervix and Uterus
Burton, E. R., & Sorosky, J. I. (2017) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/j.ogc.2017.02.009 · Cited by 6 · see citing works
Risk Analysis Stratification of CIN 2+ Development in a Cohort of Women Living with HIV with Negative Pap Smear and HR-HPV Test during a Long-Term Follow-Up
Gardella, B., Agarossi, A., Dominoni, M., et al. (2023) · Vaccines · doi:10.3390/vaccines11020265 · Cited by 5 · see citing works
Incidence of abnormal cervical and vaginal cytology among women over age 65 years living with human immunodeficiency virus
Stewart, K. A., Allen, S. M., Chesnokova, A., et al. (2019) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2019.10.011 · Cited by 5 · see citing works
Screening for Cervical Cancer
Agustiansyah, P., Sanif, R., Nurmaini, S., et al. (2021) · Bioscientia Medicina Journal of Biomedicine and Translational Research · doi:10.32539/bsm.v5i3.329 · Cited by 5 · see citing works
Detection of cervical intraepithelial neoplasia with HPVE6/E7 mRNA among women with atypical squamous cells of unknown significance
Li, Y., Rong, S., Zhi, Y., et al. (2017) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.12113 · Cited by 5 · see citing works
Vaccination in Inflammatory Bowel Disease: Utility and Future Perspective
Casella, G., Ingravalle, F., Ingravalle, A., Monti, C. M., Bonetti, F., Salvatore, F. D., Villanacci, V., & Limonta, A. (2020) · Gastrointestinal Disorders · doi:10.3390/gidisord2020019 · Cited by 4 · see citing works
Case Report: Immune Checkpoint Inhibitors as a Single Agent in the Treatment of Metastatic Cervical Cancer
Anipindi, M., Smith, R. J., & Gilani, M. A. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.856944 · Cited by 4 · see citing works
Surgical management of cervical cancer in a resource‐limited setting: One year of data from the National Cancer Institute, Sri Lanka
Patabendige, M., Wijesinghe, R. D., Wijesuriya, M. W. A. B., et al. (2020) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.13384 · Cited by 4 · see citing works
Survey of cervical cancer and precancerous lesion prevention knowledge within community health service centers in Shanghai, China
Chen, Y., Xu, Y. C., Wu, D., et al. (2019) · Medicine · doi:10.1097/md.0000000000015002 · Cited by 4 · see citing works
PERSEPSI IBU TENTANG IMUNISASI HPV PADA ANAK UNTUK PENCEGAHAN KANKER SERVIKS
Siregar, D. N., & Sunarti, S. (2020) · JUMANTIK (Jurnal Ilmiah Penelitian Kesehatan) · doi:10.30829/jumantik.v5i1.6426 · Cited by 4 · see citing works
Stability, integrity, and recovery rate of cellular nucleic acids preserved in a new liquid‐based cytology medium
Zhao, G., Liu, Z., Tian, Y., et al. (2018) · Diagnostic Cytopathology · doi:10.1002/dc.23888 · Cited by 3 · see citing works
Obstetrician-gynecologists’ practice patterns regarding HPV testing in cervical cancer screening in Turkey
Aktaş, B. A., Toptaş, T., Üreyen, I., Doğan, S., & Uysal, A. (2021) · Journal of Turkish Society of Obstetric and Gynecology · doi:10.4274/tjod.galenos.2021.36418 · Cited by 3 · see citing works
Feasibility and Acceptability of Tele-Colposcopy on the Caribbean Coast of Nicaragua: A Descriptive Mixed-Methods Study
Mitchell, E. M., Doede, A. L., Estrada, M. M., et al. (2021) · Telemedicine Reports · doi:10.1089/tmr.2021.0024 · Cited by 3 · see citing works
Hybrid capture as a tool for cervical lesions screening in HIV-infected women: insights from a Brazilian cohort
Jalil, E. M., Luz, P. M., Quintana, M. D. S. B., et al. (2017) · The Brazilian Journal of Infectious Diseases · doi:10.1016/j.bjid.2017.10.007 · Cited by 3 · see citing works
Significance of negative cervical cytology and positive HPV in the diagnosis of cervical lesions by colposcopy
Zhang, C., Liu, D., Liu, K., Xiao, H., Si, H., Wang, X., & Wang, H. (2024) · Open Medicine · doi:10.1515/med-2024-1051 · Cited by 2 · see citing works
A Study of Sensitivity of Visual Inspection of the Cervix with Acetic Acid in Cervical Cancer Screening
Rady, H. A., Gaber, Z., Agamia, A. F., & Melies, M. E.-S. (2019) · Indian Journal of Gynecologic Oncology · doi:10.1007/s40944-019-0272-7 · Cited by 2 · see citing works
Tendencias temporales del cáncer de cuello uterino invasivo en mujeres entre 20 y 39 años en Manizales, Colombia. 2003-2018
Arango, M. D. P. A. (2021) · Revista Médica de Risaralda · doi:10.22517/25395203.24621 · Cited by 2 · see citing works
The Pap Smear Test Experience of Iranian Women: A Qualitative Study
Fallahi, A., Taymoori, P., Aslibeigi, F., & Khoshravesh, S. (2021) · Journal of Education and Community Health · doi:10.52547/jech.8.4.291 · Cited by 2 · see citing works
Screening for Cervical Cancer
Agustiansyah, P., Sanif, R., Nurmaini, S., et al. (2021) · Bioscientia Medicina Journal of Biomedicine and Translational Research · doi:10.32539/bsm.v5i10.329 · Cited by 2 · see citing works
Assessing the Relationship Between Motherhood and Cervical Cancer Screening and Prevention Behaviors
Ginocchi, A., Rogan, E. M., & Conley, C. C. (2023) · Journal of Women s Health · doi:10.1089/jwh.2022.0388 · Cited by 2 · see citing works
Gynecologic Considerations for the Urologic Surgeon
Smith, A. L., & Weissbart, S. J. (2020) · Urology · doi:10.1016/j.urology.2020.05.106 · Cited by 2 · see citing works
Global burden and temporal trends of cervical cancer in women aged 60 years and older, 1990-2021: a Global Burden of Disease study
Song, Y., Ran, G., Zeng, R., & Chen, C. (2025) · International Journal of Gynecological Cancer · doi:10.1016/j.ijgc.2025.102851 · Cited by 4 · see citing works
Follow-up study on ThinPrep cytology test-positive patients in tropical regions
Chen, Y.-C., Liang, C.-N., Wang, X.-F., et al. (2022) · World Journal of Clinical Cases · doi:10.12998/wjcc.v10.i34.12543 · Cited by 1 · see citing works
A pragmatic randomized trial to compare strategies for implementing primary HPV testing for routine cervical cancer screening in a large healthcare system
Chao, C., Cannizzaro, N. T., Hahn, E. E., Shen, E., Hsu, C., Ngo‐Metzger, Q., Gould, M. K., Munoz‐Plaza, C. E., Kanter, M. H., Wride, P., et al. (2025) · Implementation Science · doi:10.1186/s13012-025-01432-9 · Cited by 2 · see citing works
Capsule Commentary on Jin et. al., Cost-Effectiveness of Primary HPV Testing, Cytology and Co-testing as Cervical Cancer Screening for Women above Age 30 Years
Walsh, J. M. E. (2016) · Journal of General Internal Medicine · doi:10.1007/s11606-016-3796-x · Cited by 1 · see citing works
Cervical Cancer Screening and the Immunosuppressed Patient: the Issues in Screening High-Risk Populations
Davis, M., Perkins, R. B., Cain, J. M., et al. (2016) · Current Obstetrics and Gynecology Reports · doi:10.1007/s13669-016-0180-0 · Cited by 1 · see citing works
Screening for Cervical Cancer and Management of Its Precursor Lesions
Johnson, J. L. (2018) · Springer eBooks · doi:10.1007/978-1-4939-7641-6_10 · Cited by 1 · see citing works
Quantity and quality in medicine: lessons from the humble Pap
Hirsch, E. (2016) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2016.06.042

Venue: Obstetrics & Gynecology
Publisher: Ovid Technologies (Wolters Kluwer Health)
Published: 2016-01
Volume: 127
Issue: 1
Pages: e1-e20
ISSN: 0029-7844 (ISSN-L)
DOI: 10.1097/aog.0000000000001263
OpenAlex: W4254573998
Cited by: 118
References: 0
Citations by year: 2026: 3 · 2025: 5 · 2024: 4 · 2023: 4 · 2022: 9 · 2021: 19 · 2020: 10 · 2019: 10 · 2018: 16 · 2017: 25 · 2016: 13
FWCI: 14.11
Type: journal article
Language: en
Open access: closed
Locations: Obstetrics and Gynecology (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Epidemiology › Cervical Cancer and HPV Research
Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Women's cancer prevention and management
Health Sciences › Medicine › Obstetrics and Gynecology › Endometrial and Cervical Cancer Treatments
Keywords: cervical cancer, cervical cancer screening, HPV testing, primary HPV testing, colposcopy, cervical cancer incidence and mortality, cancer prevention, early detection
MeSH terms: Age Factors, Carcinoma in Situ, Uterine Cervical Neoplasms, Cytological Techniques, Female, Humans, Evidence-Based Medicine, Papillomavirus Infections, Papillomavirus Vaccines, Early Detection of Cancer

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Practice Bulletin No. 157: Cervical Cancer Screening and Prevention

Abstract

Integrity signals

Claims the paper makes

Claims other papers make about this one

Cited by

Related

Record

About these checks